Methodology for assessing the properties of molecular imprinted polymers for solid phase extraction

(Note: The full text of this document is currently only available in the PDF Version )

Jørgen Olsen, Paul Martin, Ian D. Wilson and Graeme R. Jones


Abstract

Four molecular imprinted polymers (MIPs) were prepared using propranolol as template molecule. The retention and recovery of propranolol and eleven structurally related compounds were assessed on all four MIPs and a blank polymer in solid phase extraction (SPE) experiments using methanol–water–triethylamine (TEA) (1%) elution solvents. Cumulative elution curves were produced and these were compared between blank and imprinted polymer for each compound. Only one polymer demonstrated significantly different retention properties compared to the blank indicating that only this polymer was sufficiently selective to be considered for SPE. In the case of the selective MIP, two classes of compounds were observed, with one group demonstrating selective retention whilst the second group showed similar retention on both MIP and blank. The compounds showing selective retention on the MIP were closely structurally related to the template propranolol, differing in having methoxy substituents on the naphthyl or a modified alkyl side chain whilst those that were equally well retained on the blank and MIP all contained amide groups close to the secondary amino group on the side chain. The use of eleven structurally related compounds in this way enabled the key structural features important to specific binding to the molecular imprints to be explored. They also provide a means to rapidly evaluate the polymers in order to select those suitable for SPE from aqueous solutions.


References

  1. B. A. Rashid, P. Kwasowski and D. Stevenson, Pharm. Sci., 1996, 2, 115 CAS .
  2. L. I. Andersson, Anal. Chem., 1996, 68, 111 CrossRef CAS .
  3. M. Kempe and K. Mosbach, J. Chromatogr. A, 1995, 691, 317 CrossRef CAS .
  4. J. Olsen, P. Martin and I. D. Wilson, Anal. Comm., 1998, 35, 13H RSC .
  5. L. I. Andersson, A. Paprica and T. Arvidsson, Chromatographia, 1997, 46, 57 CAS .
  6. B. A. Rashid, R. J. Briggs, J. N. Hay and D. Stevenson, Anal. Commun., 1997, 34, 303 RSC .
  7. P. Martin, I. D. Wilson, G. R. Jones and K. Jones, in Drug development assay approaches; including molecular imprinting and biomarkers, ed. E. Reid, H. H. Hill and I. D. Wilson, Royal Society of Chemistry, Cambridge, 1998, p. 21 Search PubMed .
  8. B. Sellergren, Anal. Chem., 1994, 66, 1578 CrossRef CAS .
  9. J. Matsui, M. Okada, M. Tsuruoka and T. Takeuchi, Anal. Commun., 1997, 34, 85 RSC .
  10. M. T. Muldoon and L. H. Stanker, Anal. Chem., 1997, 69, 803 CrossRef CAS .
  11. P. Martin, I. D. Wilson, D. E. Morgan, G. R. Jones and K. Jones, Anal. Commun., 1997, 34, 45 RSC .
  12. B. Law, S. Weir and N. A. Ward, J. Pharm. Biomed. Anal., 1992, 10, 167 CrossRef CAS .
Click here to see how this site uses Cookies. View our privacy policy here.